BlackRock Fund Advisors’s Inovio Pharmaceuticals INO Stock Holding History

BlackRock Fund Advisors’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22M	Buy	263,805 +28,853	+12%	+$2.61M	﹤0.01%	2130
2016 Q3	$26.3M	Buy	234,952 +12,212	+5%	+$1.35M	0.01%	1939
2016 Q2	$24.7M	Sell	222,740 -10,982	-5%	-$1.33M	0.01%	1915
2016 Q1	$24.4M	Buy	233,722 +3,144	+1%	+$243K	0.01%	1870
2015 Q4	$18.6M	Sell	230,578 -10,233	-4%	-$815K	﹤0.01%	2091
2015 Q3	$16.7M	Buy	240,811 +6,240	+3%	+$544K	﹤0.01%	2108
2015 Q2	$23M	Buy	234,571 +31,437	+15%	+$3.36M	0.01%	2030
2015 Q1	$19.9M	Buy	203,134 +4,507	+2%	+$437K	﹤0.01%	2075
2014 Q4	$21.9M	Buy	198,627 +79,000	+66%	+$9.65M	0.01%	2022
2014 Q3	$14.1M	Sell	119,627 -3,896	-3%	-$485K	﹤0.01%	2163
2014 Q2	$16M	Buy	+123,523	New	+$14.6M	﹤0.01%	2137

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Fund Advisors's INO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Inovio Pharmaceuticals (INO) stake by 12% in Q4 2016, buying an estimated $2.61M and bringing the position to 263,805 shares worth $22M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

BlackRock Fund Advisors first reported a position in INO in Q2 2014 and has held it in 11 quarters since. The position peaked at $26.3M in Q3 2016. 125 funds tracked by Wall St. Rank hold INO as of Q4 2016.

BlackRock Fund Advisors held 263,805 shares of Inovio Pharmaceuticals worth $22M as of Q4 2016.
BlackRock Fund Advisors bought 28,853 Inovio Pharmaceuticals shares in Q4 2016, an estimated $2.61M.
Inovio Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2130 holding.
BlackRock Fund Advisors first reported a position in Inovio Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Inovio Pharmaceuticals position peaked at $26.3M in Q3 2016.
125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.